PGAM4 Antibodies

Santa Cruz Biotechnology provides a broad selection of PGAM4 monoclonal antibodies for research applications. PGAM4 Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphoglycerate mutase 4 (PGAM4) plays a critical role in cellular metabolism, specifically in the glycolytic pathway, where it catalyzes the conversion of 3-phosphoglycerate to 2-phosphoglycerate. PGAM4 maintains energy homeostasis and has been linked to various metabolic disorders and cancer progression. Research focused on PGAM4 continues to reveal new insights about its function in both normal cellular processes and disease states. Understanding PGAM4 regulation and activity provides valuable information for developing targeted therapeutic strategies. Investigating PGAM4 expression patterns helps identify its role in specific tissue types and cellular conditions. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific understanding of PGAM4 and its impact on human health.